Skip to main content
Top
Published in: Archives of Virology 7/2017

01-07-2017 | Original Article

Identification of a conserved conformational epitope in the VP2 protein of foot-and-mouth disease virus

Authors: Wenming Liu, Baolin Yang, Mingxia Wang, Weifeng Liang, Haiwei Wang, Decheng Yang, Wenge Ma, Guohui Zhou, Li Yu

Published in: Archives of Virology | Issue 7/2017

Login to get access

Abstract

Foot-and-mouth disease (FMD), caused by foot-and-mouth disease virus (FMDV), is a highly contagious infectious disease that affects domestic and wild cloven-hoofed animals worldwide. VP2 is a structural protein of FMDV. In this study, a potent FMDV serotype-independent monoclonal antibody (MAb) 3D9 was generated. Screening of a phage-displayed random 12-peptide library revealed that MAb 3D9 bound to phages displaying a consensus motif GVYxxAYxW that is highly homologous to the 89GVYxxxxxxxAYxxxxW105 motif in the FMDV VP2 protein. Importantly, this conformational epitope was highly conserved among all seven serotypes of FMDV analyzed in sequence alignments. To further verify the authentic epitope recognized by MAb 3D9, a FMDV O/YS/CHA/05 mutant virus V90A was generated using a reverse genetics system. The results revealed that Val90 was an important residue for MAb 3D9 binding within this conformational epitope. Thus, we finely mapped a conserved conformational epitope onto the FMDV VP2 protein. These results could be applied in the development of epitope-based vaccines and suitable MAb-based diagnostic methods for various FMDV serotype-independent tests.
Literature
2.
go back to reference Chang J, Li Y, Yang D, Wang F, Jiang Z, Yu L (2013) VP1 B-C and D–E loops of bovine enterovirus cluster B can effectively display foot-and-mouth disease virus type O-conserved neutralizing epitope. J Gen Virol 94:2691–2699CrossRefPubMed Chang J, Li Y, Yang D, Wang F, Jiang Z, Yu L (2013) VP1 B-C and D–E loops of bovine enterovirus cluster B can effectively display foot-and-mouth disease virus type O-conserved neutralizing epitope. J Gen Virol 94:2691–2699CrossRefPubMed
3.
go back to reference Cui X, Nagesha HS, Holmes IH (2003) Identification of crucial residues of conformational epitopes on VP2 protein of infectious bursal disease virus by phage display. J Virol Methods 109:75–83CrossRefPubMed Cui X, Nagesha HS, Holmes IH (2003) Identification of crucial residues of conformational epitopes on VP2 protein of infectious bursal disease virus by phage display. J Virol Methods 109:75–83CrossRefPubMed
4.
go back to reference Domingo E, Escarmís C, Baranowski E, Ruiz-Jarabo CM, Carrillo E, Núñez JI, Sobrino F (2003) Evolution of foot-and-mouth disease virus. Virus Res 91:47–63CrossRefPubMed Domingo E, Escarmís C, Baranowski E, Ruiz-Jarabo CM, Carrillo E, Núñez JI, Sobrino F (2003) Evolution of foot-and-mouth disease virus. Virus Res 91:47–63CrossRefPubMed
5.
go back to reference Fisher CL, Pei GK (1997) Modification of a PCR-based site-directed mutagenesis method. Biotechniques 23:570–574PubMed Fisher CL, Pei GK (1997) Modification of a PCR-based site-directed mutagenesis method. Biotechniques 23:570–574PubMed
6.
go back to reference Freiberg B, Höhlich B, Haas B, Saalmüller A, Pfaff E, Marquardt O (2001) Type-independent detection of foot-and-mouth disease virus by monoclonal antibodies that bind to amino-terminal residues of capsid protein VP2. J Virol Methods 92:199–205CrossRefPubMed Freiberg B, Höhlich B, Haas B, Saalmüller A, Pfaff E, Marquardt O (2001) Type-independent detection of foot-and-mouth disease virus by monoclonal antibodies that bind to amino-terminal residues of capsid protein VP2. J Virol Methods 92:199–205CrossRefPubMed
8.
go back to reference Gustafsson E, Haas P-J, Walse B, Hijnen M, Furebring C, Ohlin M, van Strijp JAG, van Kessel KPM (2009) Identification of conformational epitopes for human IgG on Chemotaxis inhibitory protein of Staphylococcus aureus. BMC Immunol 10:13CrossRefPubMedPubMedCentral Gustafsson E, Haas P-J, Walse B, Hijnen M, Furebring C, Ohlin M, van Strijp JAG, van Kessel KPM (2009) Identification of conformational epitopes for human IgG on Chemotaxis inhibitory protein of Staphylococcus aureus. BMC Immunol 10:13CrossRefPubMedPubMedCentral
9.
go back to reference Have P, Lei JC, Schjerning-Thiesen K (1984) An enzyme-linked immunosorbent assay (ELISA) for the primary diagnosis of foot-and-mouth disease. Characterization and comparison with complement fixation. Acta Vet Scand 25:280–296PubMed Have P, Lei JC, Schjerning-Thiesen K (1984) An enzyme-linked immunosorbent assay (ELISA) for the primary diagnosis of foot-and-mouth disease. Characterization and comparison with complement fixation. Acta Vet Scand 25:280–296PubMed
10.
11.
go back to reference Kitson JDA, McCahon D, Belsham GJ (1990) Sequence analysis of monoclonal antibody resistant mutants of type O foot and mouth disease virus: Evidence for the involvement of the three surface exposed capsid proteins in four antigenic sites. Virology 179:26–34CrossRefPubMed Kitson JDA, McCahon D, Belsham GJ (1990) Sequence analysis of monoclonal antibody resistant mutants of type O foot and mouth disease virus: Evidence for the involvement of the three surface exposed capsid proteins in four antigenic sites. Virology 179:26–34CrossRefPubMed
12.
go back to reference Kohler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495–497CrossRefPubMed Kohler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495–497CrossRefPubMed
13.
go back to reference Kolaskar AS, Tongaonkar PC (1990) A semi-empirical method for prediction of antigenic determinants on protein antigens. FEBS Lett 276:172–174CrossRefPubMed Kolaskar AS, Tongaonkar PC (1990) A semi-empirical method for prediction of antigenic determinants on protein antigens. FEBS Lett 276:172–174CrossRefPubMed
14.
go back to reference Li C, Liang W, Liu W, Yang D, Wang H, Ma W, Zhou G, Yu L (2016) Identification of a conserved linear epitope using a monoclonal antibody against non-structural protein 3B of foot-and-mouth disease virus. Arch Virol 161:365–375CrossRefPubMed Li C, Liang W, Liu W, Yang D, Wang H, Ma W, Zhou G, Yu L (2016) Identification of a conserved linear epitope using a monoclonal antibody against non-structural protein 3B of foot-and-mouth disease virus. Arch Virol 161:365–375CrossRefPubMed
15.
go back to reference Liang W, Zhou G, Liu W, Yang B, Li C, Wang H, Yang D, Ma W, Yu L (2016) Identification of a conserved linear neutralizing epitope recognized by monoclonal antibody 9A9 against serotype A foot-and-mouth disease virus. Arch Virol 161:2705–2716CrossRefPubMed Liang W, Zhou G, Liu W, Yang B, Li C, Wang H, Yang D, Ma W, Yu L (2016) Identification of a conserved linear neutralizing epitope recognized by monoclonal antibody 9A9 against serotype A foot-and-mouth disease virus. Arch Virol 161:2705–2716CrossRefPubMed
16.
go back to reference Lin-Fa W, Meng Y (2004) Epitope identification and discovery using phage display libraries: applications in vaccine development and diagnostics. Curr Drug Targets 5:1–15 Lin-Fa W, Meng Y (2004) Epitope identification and discovery using phage display libraries: applications in vaccine development and diagnostics. Curr Drug Targets 5:1–15
17.
go back to reference Marquardt O, Rahman MM, Freiberg B (2000) Genetic and antigenic variance of foot-and-mouth disease virus type Asia1. Arch Virol 145:149–157CrossRefPubMed Marquardt O, Rahman MM, Freiberg B (2000) Genetic and antigenic variance of foot-and-mouth disease virus type Asia1. Arch Virol 145:149–157CrossRefPubMed
18.
go back to reference Mateu MG, Hernández J, Martínez MA, Feigelstock D, Lea S, Pérez JJ, Giralt E, Stuart D, Palma EL, Domingo E (1994) Antigenic heterogeneity of a foot-and-mouth disease virus serotype in the field is mediated by very limited sequence variation at several antigenic sites. J Virol 68:1407–1417PubMedPubMedCentral Mateu MG, Hernández J, Martínez MA, Feigelstock D, Lea S, Pérez JJ, Giralt E, Stuart D, Palma EL, Domingo E (1994) Antigenic heterogeneity of a foot-and-mouth disease virus serotype in the field is mediated by very limited sequence variation at several antigenic sites. J Virol 68:1407–1417PubMedPubMedCentral
19.
go back to reference Muller JD, McEachern JA, Bossart KN, Hansson E, Yu M, Clavijo A, Hammond JM, Wang L-F (2008) Serotype-independent detection of foot-and-mouth disease virus. J Virol Methods 151:146–153CrossRefPubMed Muller JD, McEachern JA, Bossart KN, Hansson E, Yu M, Clavijo A, Hammond JM, Wang L-F (2008) Serotype-independent detection of foot-and-mouth disease virus. J Virol Methods 151:146–153CrossRefPubMed
20.
go back to reference Rodi DJ, Makowski L (1999) Phage-display technology—finding a needle in a vast molecular haystack. Curr Opin Biotechnol 10:87–93CrossRefPubMed Rodi DJ, Makowski L (1999) Phage-display technology—finding a needle in a vast molecular haystack. Curr Opin Biotechnol 10:87–93CrossRefPubMed
21.
go back to reference Roeder PL, Le Blanc Smith PM (1987) Detection and typing of foot-and-mouth disease virus by enzyme-linked immunosorbent assay: a sensitive, rapid and reliable technique for primary diagnosis. Res Vet Sci 43:225–232PubMed Roeder PL, Le Blanc Smith PM (1987) Detection and typing of foot-and-mouth disease virus by enzyme-linked immunosorbent assay: a sensitive, rapid and reliable technique for primary diagnosis. Res Vet Sci 43:225–232PubMed
22.
go back to reference Rowley MJ, O’Connor K, Wijeyewickrema L (2004) Phage display for epitope determination: a paradigm for identifying receptor–ligand interactions. Biotechnol Annu Rev 10:151–188CrossRefPubMed Rowley MJ, O’Connor K, Wijeyewickrema L (2004) Phage display for epitope determination: a paradigm for identifying receptor–ligand interactions. Biotechnol Annu Rev 10:151–188CrossRefPubMed
23.
go back to reference Samuel AR, Knowles NJ, Samuel GD, Crowther JR (1991) Evaluation of a trapping ELISA for the differentiation of foot-and-mouth disease virus strains using monoclonal antibodies. Biologicals 19:299–310CrossRefPubMed Samuel AR, Knowles NJ, Samuel GD, Crowther JR (1991) Evaluation of a trapping ELISA for the differentiation of foot-and-mouth disease virus strains using monoclonal antibodies. Biologicals 19:299–310CrossRefPubMed
24.
go back to reference Sibille P, Strosberg AD (1997) A FIV epitope defined by a phage peptide library screened with a monoclonal anti-FIV antibody. Immunol Lett 59:133–137CrossRefPubMed Sibille P, Strosberg AD (1997) A FIV epitope defined by a phage peptide library screened with a monoclonal anti-FIV antibody. Immunol Lett 59:133–137CrossRefPubMed
25.
go back to reference Sun C, Yang D, Gao R, Liang T, Wang H, Zhou G, Yu L (2016) Modification of the internal ribosome entry site element impairs the growth of foot-and-mouth disease virus in porcine-derived cells. J Gen Virol 97:901–911CrossRefPubMedPubMedCentral Sun C, Yang D, Gao R, Liang T, Wang H, Zhou G, Yu L (2016) Modification of the internal ribosome entry site element impairs the growth of foot-and-mouth disease virus in porcine-derived cells. J Gen Virol 97:901–911CrossRefPubMedPubMedCentral
26.
go back to reference Wang H, Zhao L, Li W, Zhou G, Yu L (2011) Identification of a conformational epitope on the VP1 G-H Loop of type Asia1 foot-and-mouth disease virus defined by a protective monoclonal antibody. Vet Microbiol 148:189–199CrossRefPubMed Wang H, Zhao L, Li W, Zhou G, Yu L (2011) Identification of a conformational epitope on the VP1 G-H Loop of type Asia1 foot-and-mouth disease virus defined by a protective monoclonal antibody. Vet Microbiol 148:189–199CrossRefPubMed
27.
go back to reference Yang D, Zhang C, Zhao L, Zhou G, Wang H, Yu L (2011) Identification of a conserved linear epitope on the VP1 protein of serotype O foot-and-mouth disease virus by neutralising monoclonal antibody 8E8. Virus Res 155:291–299CrossRefPubMed Yang D, Zhang C, Zhao L, Zhou G, Wang H, Yu L (2011) Identification of a conserved linear epitope on the VP1 protein of serotype O foot-and-mouth disease virus by neutralising monoclonal antibody 8E8. Virus Res 155:291–299CrossRefPubMed
28.
go back to reference Yang M, Clavijo A, Suarez-Banmann R, Avalo R (2007) Production and characterization of two serotype independent monoclonal antibodies against foot-and-mouth disease virus. Vet Immunol Immunopathol 115:126–134CrossRefPubMed Yang M, Clavijo A, Suarez-Banmann R, Avalo R (2007) Production and characterization of two serotype independent monoclonal antibodies against foot-and-mouth disease virus. Vet Immunol Immunopathol 115:126–134CrossRefPubMed
29.
go back to reference Yu Y, Wang H, Zhao L, Zhang C, Jiang Z, Yu L (2011) Fine mapping of a foot-and-mouth disease virus epitope recognized by serotype-independent monoclonal antibody 4B2. J Microbiol 49:94–101CrossRefPubMed Yu Y, Wang H, Zhao L, Zhang C, Jiang Z, Yu L (2011) Fine mapping of a foot-and-mouth disease virus epitope recognized by serotype-independent monoclonal antibody 4B2. J Microbiol 49:94–101CrossRefPubMed
30.
go back to reference Zhang F, Yu M, Weiland E, Morrissy C, Zhang N, Westbury H, Wang LF (2006) Characterization of epitopes for neutralizing monoclonal antibodies to classical swine fever virus E2 and Erns using phage-displayed random peptide library. Arch Virol 151:37–54CrossRefPubMed Zhang F, Yu M, Weiland E, Morrissy C, Zhang N, Westbury H, Wang LF (2006) Characterization of epitopes for neutralizing monoclonal antibodies to classical swine fever virus E2 and Erns using phage-displayed random peptide library. Arch Virol 151:37–54CrossRefPubMed
Metadata
Title
Identification of a conserved conformational epitope in the VP2 protein of foot-and-mouth disease virus
Authors
Wenming Liu
Baolin Yang
Mingxia Wang
Weifeng Liang
Haiwei Wang
Decheng Yang
Wenge Ma
Guohui Zhou
Li Yu
Publication date
01-07-2017
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 7/2017
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-017-3304-6

Other articles of this Issue 7/2017

Archives of Virology 7/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.